ImmunoMet Therapeutics corporate office is located in 2450 Holcombe Blvd, Houston, Texas, 77021, United States and has 11-50 employees.
immunomet therapeutics
immunomet therapeutics inc
immunomet
immunomet therapeutics inc
immunomet therapeutics
usimmunomet therapeutics inc
| Location | People at location |
| North America | 1-10 |
Explore people who held key positions, contributed to ImmunoMet Therapeutics's success, and advanced their careers.
Chief Marketing Office... at Asher Biotherapeutics
Worked as Consultant Chief Marketing Officer
at ImmunoMet Therapeutics (2022-2024)
Global Project Manager... at Celerion
Worked as Clinical Trial Associate & Manager
at ImmunoMet Therapeutics (2016-2022)
Senior Vice President ... at Qureator
Worked as Vice President Head of Biology
at ImmunoMet Therapeutics (2015-2020)
Investor Relations Spe... at Voltron Therapeutics
Worked as Investor Relations and Communications
at ImmunoMet Therapeutics (2016-2018)
Graduate Research Assi... at University of North Ca...
Worked as Research Intern
at ImmunoMet Therapeutics (2017-2017)
Adjunct Assistant Prof... at Robert Wood Johnson Fo...
Worked as Chief Medical Officer
at ImmunoMet Therapeutics (2018-2021)
Explore More
ImmunoMet Therapeutics is a clinical-stage oncology company focused on developing novel cancer drugs by targeting metabolic dependencies in resistant tumors. Their lead asset, lixumistat (IM156), is a best-in-class OxPhos inhibitor that aims to improve treatment options for patients with advanced pancreatic cancer. The company has shown promising e... Read More